Literature DB >> 26936730

A Monte Carlo study on the collimation of pencil beam scanning proton therapy beams.

Frances C Charlwood1, Adam H Aitkenhead1, Ranald I Mackay1.   

Abstract

PURPOSE: The lateral edge of a proton therapy beam is commonly used to achieve conformality to the treatment volume where critical structures reside close to the target. However, when treating shallow depths, the lateral edge of a pencil beam scanning (PBS) system may be broader than that of a double scattered (DS) system. Use of a range-shifter to degrade the beam and allow treatment of very shallow depths further blurs the lateral edge. The authors investigate the potential use of a collimator with a PBS system for delivery of 3D uniform dose-volumes to a water-tank phantom, identifying the key factors controlling the width of the lateral edge.
METHODS: The geant4 application for tomographic emission (gate) Monte Carlo (MC) environment was used, following validation against previously published data. Key parameters for PBS beams were investigated to assess their impact on the lateral edge of both monoenergetic beams and uniform dose-volumes. These parameters included nozzle-to-surface distance (NSD), vacuum window-to-surface distance (VSD), use of a range-shifter, and spot optimization parameters.
RESULTS: The lateral edge of an uncollimated PBS beam is particularly sensitive to VSD and NSD. While use of a range-shifter blurs the lateral edge, collimation allows the edge to be sharpened to between 2 and 4 mm depending on the depth of the target. Optimization of the spot weightings alone can provide a penumbral width close to that of a single spot, but also leads to poorer uniformity near the edge of the target volume.
CONCLUSIONS: Collimation of PBS beams should be considered for superficial targets particularly for beams delivered through a range-shifter, since the resultant sharpening of the lateral edge will allow improved sparing of adjacent normal tissues. Further work is needed to develop collimators which are integrated into both nozzle designs and planning system optimization algorithms.

Entities:  

Mesh:

Year:  2016        PMID: 26936730     DOI: 10.1118/1.4941957

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  5 in total

1.  Trimmer sequencing time minimization during dynamically collimated proton therapy using a colony of cooperating agents.

Authors:  Blake R Smith; Daniel E Hyer; Ryan T Flynn; Patrick M Hill; Wesley S Culberson
Journal:  Phys Med Biol       Date:  2019-10-21       Impact factor: 3.609

2.  Evaluation of dosimetric advantages of using patient-specific aperture system with intensity-modulated proton therapy for the shallow depth tumor.

Authors:  Keisuke Yasui; Toshiyuki Toshito; Chihiro Omachi; Kensuke Hayashi; Kenichiro Tanaka; Kumiko Asai; Akira Shimomura; Rie Muramatsu; Naoki Hayashi
Journal:  J Appl Clin Med Phys       Date:  2017-11-27       Impact factor: 2.102

3.  Proton therapy for non-squamous cell carcinoma of the head and neck: planning comparison and toxicity.

Authors:  Hiromitsu Iwata; Toshiyuki Toshito; Kensuke Hayashi; Maho Yamada; Chihiro Omachi; Koichiro Nakajima; Yukiko Hattori; Shingo Hashimoto; Yo Kuroda; Yoshihide Okumura; Jun-Etsu Mizoe; Hiroyuki Ogino; Yuta Shibamoto
Journal:  J Radiat Res       Date:  2019-10-23       Impact factor: 2.724

4.  Impact of different treatment techniques for pediatric Ewing sarcoma of the chest wall: IMRT, 3DCPT, and IMPT with/without beam aperture.

Authors:  Zhong Su; Daniel J Indelicato; Raymond B Mailhot; Julie A Bradley
Journal:  J Appl Clin Med Phys       Date:  2020-04-08       Impact factor: 2.102

5.  Dose distribution of intensity-modulated proton therapy with and without a multi-leaf collimator for the treatment of maxillary sinus cancer: a comparative effectiveness study.

Authors:  Soichi Sugiyama; Kuniaki Katsui; Yuki Tominaga; Takahiro Waki; Norihisa Katayama; Hidenobu Matsuzaki; Shin Kariya; Masahiro Kuroda; Kazunori Nishizaki; Susumu Kanazawa
Journal:  Radiat Oncol       Date:  2019-11-21       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.